Journal
DRUG DISCOVERY TODAY
Volume 19, Issue 5, Pages 654-660Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2013.11.012
Keywords
-
Categories
Ask authors/readers for more resources
Lysine acetylation is a reversible post-translational modification (PTM) of cellular proteins and represents an important regulatory switch in signal transduction. Lysine acetylation, in combination with other PTMs, directs the outcomes as well as the activation levels of important signal transduction pathways such as the nuclear factor (NF)-kappa B pathway. Small molecule modulators of the 'writers' (HATs) and 'erasers' (HDACs) can regulate the NF-kappa B pathway in a specific manner. This review focuses on the effects of frequently used HAT and HDAC inhibitors on the NF-kappa B signal transduction pathway and inflammatory responses, and their potential as novel therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available